Latest News

CTC Director receives award from the Vice-Chancellor

Professor John Simes, CTC director, has just been awarded the University of Sydney's Vice-Chancellor's Award for Excellence. It acknowledges his exceptional research at the university. He is a pr... Read More

The cost of new drugs for cancer is creating challenges for patients and their doctors

When drugs are not subsidised by the government, and a doctor feels that a drug would be worthwhile, another way of paying must be found. Some of these treatments are very expensive. In some cases... Read More

Benefits of Investigator-initiated trials exceed their costs

The Australian Clinical Trials Alliance (ACTA) and the Australian Commission on Safety and Equality in Health Care have published a landmark report outlining the economic benefits of investigator-... Read More

More funds for clinical trials and an award for BOOST II

There was double good news for clinical trials this morning at the ACTA Clinical Trials 2017: National Tribute and Awards Ceremony held at Royal Prince Alfred Hospital. First, federal Minister fo... Read More

Published Research

Discussing and prescribing expensive unfunded anticancer drugs in Australia

ESMO Open 2017; 2(2): e000170

Karikios DJ, Mileshkin L, Martin A, Ferraro D, Stockler MR

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Lancet Oncology. Online 7 Aug 2017.

Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A, van Hazel G, Sharma RA

How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists

Supportive Care in Cancer 2017. Online 5 Aug 2017

Moth EB, Kiely BE, Naganathan V, Martin A, Blinman P

Predictors of incident heart failure in patients after an acute coronary syndrome: the LIPID heart failure risk-prediction model

International Journal of Cardiology. Online 22 Jul 2017

Driscoll A, Barnes EH, Blankenberg S, Colquhoun DM, Hunt D, Nestel PJ, Stewart RA, West MJ, White HD, Simes J, Tonkin A

See more publications

Upcoming Events and Courses

Careers at CTC

Current Vacancies

Research Fellow - Health Economist